Volker Lang

Nessuna posizione attualmente

64 anni

Health Technology

Consumer Services

Profilo

Volker Lang has been Vice President of Business Development for PIERIS Proteolab AG since August 2003.
He was the Head of Business Development and Chief Operating Officer of Cosmix GmbH.
He was responsible for developing microbial production systems at UCB-Celltech and managing biopharmaceutical projects at Fresenius-Kabi.
He received a PhD from Technical University of Braunschweig.

Precedenti posizioni note di Volker Lang

Società	Posizione	Fine
Affimed NV Niederlassung Deutschland Affimed NV Niederlassung Deutschland Pharmaceuticals: MajorHealth Technology Affimed NV Niederlassung Deutschland discovers and develops antibody-based therapeutic drugs. The firm generates and develops a pipeline of antibody product candidates based on proprietary technology platform. It offer therapeutic drugs that target autoimmune diseases and tumor cells. The company was founded in 2000 and is headquartered in Heidelberg, Germany.	Corporate Officer/Principal	13/04/2010
Pieris AG Pieris AG BiotechnologyHealth Technology Pieris AG develops and markets Anticalin-brand proteins. The firm specializes in the research and development of its Anticalin technology, with focus on deriving therapeutic proteins from human lipocalins. It focuses on solving pharmacological and pharmaceutical limitations of both protein- and non-protein-based drug platforms. It offers a pipeline of Anticalin therapeutics that has active and multi-program research and development collaborations with biopharmaceutical companies. The company was founded by Arne Skerra, Steffen Schlehuber, and Claus Schalper in 2001 and is headquartered in Freising, Germany.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Volker Lang

Formazione di Volker Lang

Technische Universität Braunschweig

Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private